Disclosure of Director Relevant Interests

Disclosure of Director Relevant Interests Name of listed issuer: Fisher & Paykel Healthcare Corporation Limited Date this disclosure made: 4-Apr-17 Date of last disclosure: 23-Sep-16 Director or senior manager giving disclosure Full name(s): Michael Grenfell DANIELL Name of listed issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in listed issuer: Director Summary of acquisition or disposal of relevant interest (excluding specified derivatives) Class of affected quoted financial products: Ordinary Shares Nature of the affected relevant interest(s): Beneficial Interest in Ordinary Shares For that relevant interest- Number held in class before sale and exercise: "(a) 342,970 Ordinary shares (b) 530,000 Options to acquire Ordinary Shares" Number held in class after sale and exercise: "(a) 332,366 Ordinary Shares (b)480,000 Options to acquire Ordinary Shares" Current registered holder(s): " Michael Grenfell DANIELL" Registered holder(s) once transfers are registered: " Michael Grenfell DANIELL " Summary of acquisition or disposal of specified derivatives relevant interest (if applicable) Type of affected derivative: Not applicable Class of underlying financial products: Details of affected derivative- The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): A statement as to whether the derivative is cash settled or physically settled: Maturity date of the derivative (if any): Expiry date of the derivative(if any): The price specified in the terms of the derivative (if any): Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: For that derivative,- Parties to the derivative: If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative: Details of transactions giving rise to acquisition or disposal Total number of transactions to which notice relates: Four Details of transactions requiring disclosure- Date of transaction: "(a) 31/03/2017 (b) 29,30,31/03/2017" Nature of transaction: (a) Exercise of 50,000 Options and issue of 39,396 Ordinary Shares and (b) Sale of 50,000 Ordinary Shares Name of any other party or parties to the transaction (if known): The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value, describe the consideration: "(a) NZ$382,141.20 (b) NZ$483,787.01" Number of financial products to which the transaction related: "(a) 50,000 Ordinary Shares and (b) 39,396 Ordinary Shares" If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details-- Whether relevant interests were acquired or disposed of during a closed period: No Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the closed period: Not applicable Date of the prior written clearance (if any): Not applicable Summary of other relevant interests after acquisition or disposal: Class of quoted financial products: Nature of relevant interest: (a) Daniell Family Trust - Trustee & Beneficiary (b) Performance Share Rights over Ordinary Shares For that relevant interest,- Number held in class: (a) 669,109 Ordinary Shares (b) 80,000 PSRs over Ordinary Shares Current registered holder(s): (a) Daniell Family Trust (b) Michael Grenfell DANIELL For a derivative relevant interest,- Type of derivative: Details of derivative,- The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): A statement as to whether the derivative is cash settled or physically settled: Maturity date of the derivative (if any): Expiry date of the derivative (if any): The price's specified terms (if any): Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: For that derivative relevant interest,- Parties to the derivative: If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative: Certification I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. End CA:00299396 For:FPH Type:RELINT Time:2017-04-04 13:46:18